Ecopipam reduces relapse risk in pediatric Tourette syndrome
1. Ecopipam is a first-in-class investigational selective dopamine D1 receptor antagonist under priority review for pediatric Tourette syndrome, offering a ...
Tag: pediatric neurology
Fetal cerebrovascular response to maternal hyperoxia testing may help predict neurodevelopmental outcomes
Fetal Cerebrovascular Response to Maternal Hyperoxia Testing and Association With Brain Growth and Postnatal Brain Injury in Congenital Heart Disease ...
Similar recovery course noted for both sports and non-sport-related concussion in children
1. Symptom recovery trajectories in children aged 5 to 12 years of age suffering from sport-related concussions (SRCs) and non-sport-related ...
Overground robot-assisted gait training may be effective in children with cerebral palsy
1. Overground Robot-assisted gait training (RAGT), using a new torque-assisted wearable exoskeletal robot significantly improved gross motor function and gait ...
Associations found between maternal pre-pregnancy body mass index and infant striatal mean diffusivity
1. Tissue density in the left caudate nucleus was significantly decreased in infants whose mothers had elevated pre-pregnancy body-mass indexes ...
Low dose prenatal tobacco and alcohol result in long lasting changes on electroencephalogram
1. In this cohort study, children with low dose prenatal alcohol and tobacco exposure were found to have differences in ...
Adjuvant erythropoietin therapy does not improve survival in newborns with hypoxic-ischemic encephalopathy
1. Erythropoietin administration did not lower the risk of death or neurodevelopmental impairment in newborns with hypoxic-ischemic encephalopathy as compared ...
Early treatment of seizures in newborns associated with decreased seizure burden and frequency.
Neonatal seizure management – Is the timing of treatment critical? 1. In a cohort of newborn infants, treatment of seizures ...
Levetiracetam not clinically effective nor cost-effective compared to valproate for newly diagnosed generalized or unclassified epilepsy
1. 12-month remission was superior with valproate than with levetiracetam. 2. Compared to levetiracetam, patients in the valproate group reported ...
Lamotrigine offers higher net health benefits and is more cost-effective than levetiracetam and zonisamide as first-line focal epilepsy treatment
1. Lamotrigine offered greater clinical benefit, fewer adverse reactions, and higher cost-utility normalized to quality-adjusted life years compared to levetiracetam ...
